Andrew Aswani: How NETs Contribute to Disease and Why They Matter
Andrew Aswani, Co-Founder, Chief Medical Officer at Santersus AG shared a post on LinkedIn about a recent article by Michal Santocki and Elzbieta Kolaczkowska, published in Cells:
”The growing body of research on neutrophil extracellular traps (NETs) continues to reshape our understanding of inflammation, immunity, and thrombosis.
This 2020 foundational MDPI review on immune‑complex-induced NETosis highlights that NETs are not just byproducts of inflammation-they are active drivers of vascular injury, coagulation, and organ dysfunction.
When NETs accumulate unchecked, they create a cascade of endothelial damage, platelet activation, and immune dysregulation that underpins some of the most severe conditions we face-sepsis, autoimmune disease, cancer, and cardiovascular complications.
At Santersus AG, we’re working to help clinicians intervene at this root cause. Our NucleoCapture platform is designed to selectively remove NETs from circulation, offering a targeted, extracorporeal approach that avoids the systemic side effects of many pharmacologic therapies. As the scientific community continues to validate the central role of NETs in immune‑driven thrombosis, the need for NET‑focused interventions becomes even more urgent.
This research strengthens the case for a new therapeutic paradigm-one that doesn’t just modulate inflammation, but directly removes the molecular drivers of immune‑mediated injury.”
Title: On Neutrophil Extracellular Trap (NET) Removal: What We Know Thus Far and Why So Little
Authors: Michal Santocki, Elzbieta Kolaczkowska
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 17, 2026, 09:49Jeevandeep Mishra: Thrombotic Complications and Risk in COVID-19
-
Apr 17, 2026, 09:25The Challanges of Cancer-Associated Thrombosis – ISTH
-
Apr 17, 2026, 08:32Leslie Johns: Our First Low Titer O Whole Blood Products
-
Apr 17, 2026, 08:24Dominique P. Germain: The Critical Role of Cardiac Involvement in Fabry Disease
-
Apr 17, 2026, 07:54Pat Garcia-Gonzalez: Does Having Lifesaving Medicine at a Hospital Guarantee Patient Access?
-
Apr 17, 2026, 05:41Tareq Abadl: Sickle Cell Anemia is Not Just Hemoglobin Deficiency, It’s a Genetic Mutation
-
Apr 17, 2026, 04:58Emmanuel J Favaloro: A Century of von Willebrand Disease – From Discovery to Modern Diagnostic Pathways
-
Apr 17, 2026, 02:41Helena Bradbury: First Haematology EAHAD Supplement of 2026
-
Apr 16, 2026, 18:27Are We Underestimating VTE After PanNET Surgery? – RPTH Journal